查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404775

日本次世代定序市场规模、份额、趋势分析报告：按技术、按产品、按应用、按工作流程、按最终用途、细分市场预测，2024-2030 年

Japan Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Targeted Sequencing & Resequencing), By Product (Platforms, Consumables) By Application, By Workflow, By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

日本次世代定序市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年日本次世代定序市场规模将达到13.0567亿美元，2024年至2030年复合年增长率为23.60%。

伴随伴同性、个人化医疗的进步以及 NGS 技术临床机会的增加等因素预计将推动市场成长。此外，由于消费者需求旺盛而导致市场竞争加剧以及专注于开发次世代定序产品和服务的市场参与者的崛起也是推动产业需求向前发展的重要因素。

成本下降正在加速次世代定序在临床环境中的采用。此外，对基于临床的 NGS 解决方案的需求不断增长预计将在预测期内推动次世代定序产业的发展。基因组定序和 MPSS/NGS 的使用已成为罕见疾病诊断和分析、治疗标靶识别和产前检测的必要条件。 NGS 预计将在遗传性疾病和感染疾病的治疗中得到更多采用。此外，该公司还针对罕见疾病和遗传疾病提供基于 NGS 的产品和服务。例如，2023年1月，日本NGS服务供应商Twist Bioscience Co., Ltd.宣布推出三款NGS标靶富集panel，支持遗传性癌症研究和罕见疾病并辅助诊断。在该国运营的主要企业推出的此类产品预计将在预测期内推动市场成长。

伴同性诊断和个人化医疗的发展预计将推动次世代定序产品和服务的采用。多位肿瘤学家预测，NGS与伴同性诊断相结合将在个体化诊断和治疗中发挥重要作用，NGS应用的需求将大幅增加。此外，监管机构也支持使用 NGS 进行伴同性诊断。例如，2021 年 9 月，日本厚生劳动省核准了Thermo Fisher Scientific 的伴同性诊断 (CDx) Oncomine Dx Target Test。 Oncomin 检测已被核准为基于 NGS 的肺癌伴随诊断。此类新兴市场的开拓，加上监管支持，预计将在预测期内推动市场成长。

日本次世代定序市场报告亮点

  • 按产品划分，耗材细分市场在 2023 年占据行业主导地位，销售份额为 74.0%，这种主导地位可归因于较低的测序成本和领先企业增加耗材的推出。
  • 按应用划分，肿瘤学是 2023 年该行业最大的收益贡献者。相较之下，由于个人健康意识、亲子鑑定和系谱创建的快速发展，消费者基因组学领域预计将成长最快。
  • 基于工作流程，定序细分市场将在 2023 年占据主导地位。由于可用的定序平台多种多样，该细分市场收益丰厚。
  • 从技术角度来看，标靶定序和重测序领域预计将在 2023 年占据行业主导地位，并在预测期内实现最高成长率。
  • 根据最终用途，学术研究领域将在 2023 年占据行业主导地位，因为许多学术机构都提供生物资讯学课程。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 日本次世代定序市场的变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 日本次世代定序市场分析工具
    • SWOT 分析；按因素（政治、法律、经济、技术）
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第四章日本次世代定序市场：技术业务分析

  • 次世代定序市场：技术变化分析
  • 标靶定序和定序
  • 全基因组序列测定
  • 全EXOME定序

第五章日本次世代定序市场：产品业务分析

  • 次世代定序市场：产品变异分析
  • 平台
  • 消耗品
    • 样品製备
    • 目标强化
    • 其他的

第六章 日本次世代定序市场：应用业务分析

  • 次世代定序市场：应用变化分析
  • 肿瘤学
    • 诊断和筛检
    • 研究性学习
  • 临床调查
    • 感染疾病
    • 特发性疾病
    • 遗传疾病
    • 非传染性疾病/其他疾病
  • 生殖健康
    • NIPT
    • PGT
    • 新生儿基因筛检
    • 单基因分析
  • HLA型检测/免疫系统监测
  • 宏基因体学、流行病学、药物研发
  • 农业基因组学与法医学
  • 消费者基因体学

第七章 日本次世代定序市场：工作流程业务分析

  • 次世代定序市场：工作流程变异分析
  • 预测定序
  • 定序
  • 资料分析
    • 原始资料NG分析
    • 二次资料分析
    • 三级资料分析

第八章日本次世代定序市场：最终用途业务分析

  • 次世代定序市场：最终用途变异分析
  • 学术研究
  • 临床调查
  • 医院和诊所
  • 製药和生物技术公司
  • 其他用户

第9章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
  • 2023年主要企业市场占有率分析
  • Participants Overview
    • Illumina, Inc
    • QIAGEN
    • Thermo Fisher Scientific, Inc
    • BGI
    • Pacific Biosciences
    • Bio Rad Laboratories
    • Oxford Nanopore Technologies, Inc
    • Myriad Genetics. Inc.
    • Agilent Technologies, Inc.
    • Eurofins Scientific
Product Code: GVR-4-68040-156-5

Japan Next Generation Sequencing Market Growth & Trends:

The Japan next generation sequencing market size is expected to reach USD 1,305.67 million by 2030, registering a CAGR of 23.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the development of companion diagnostics and personalized medicine and rising clinical opportunities for NGS technology are projected to drive the market growth. In addition, rising competition in the market owing to high consumer demand and the rising emphasis of market players to develop next-generation sequencing products and services is another vital factor propelling industry demand forward.

With lowering costs, the adoption of next-generation sequencing in the clinical setting is boosting. Moreover, an increase in the demand for clinic-based NGS solutions is anticipated to propel the next generation sequencing industry over the forecast period. The utilization of genome sequencing and MPSS /NGS has become necessary for the diagnosis & analysis of rare diseases, and recognizing therapeutic targets, and for prenatal testing. NGS is anticipated to witness rising adoption in hereditary diseases and infectious disorder treatment. Furthermore, companies are providing products and services based on NGS for rare and hereditary diseases. For instance, in January 2023, Twist Bioscience Corporation, An NGS service provider in Japan, introduced three NGS target enrichment panels to support hereditary cancer research and rare diseases and support diagnostics. Such product launches by key players operating in the country are anticipated to drive market growth over the forecast period.

The developments of companion diagnostics and personalized medicines are anticipated to drive the adoption of next-generation sequencing products and services. Several oncologists expected that NGS combined with companion diagnostics could play a major role in personalized diagnostics and therapeutics, significantly increasing the demand for NGS applications. Furthermore, regulatory authorities are also supporting the use of NGS for companion diagnostics. For instance, in September 2021, the Ministry of Health, Labour, and Welfare (MHLW), Japan, authorized the Oncomine Dx Target Test, a companion diagnostic (CDx) from Thermo Fisher Scientific Inc. The Oncomine test was approved as an NGS-based CDx for lung cancer. Such developments, coupled with regulatory support, are anticipated to boost the market growth over the forecast period.

Japan Next Generation Sequencing Market Report Highlights:

  • Based on product, the consumables segment dominated the industry in 2023 with a revenue share of 74.0%, and this dominance can be attributed to the decrease in sequencing costs and increasing launches of consumables by major players
  • Based on application, the oncology segment was the largest revenue contributor for the industry in 2023. In contrast, the consumer genomics segment is expected to witness the fastest growth owing to the rapid development in personal health awareness, paternity testing, and genealogy
  • Based on workflow, the sequencing segment dominated the market in 2023. The higher revenue of the segment is attributed to the availability of various sequencing platforms
  • Based on technology, the targeted sequencing & resequencing segment dominated the industry in 2023 and is projected to register the highest growth rate during the forecast period
  • Based on end-use, the academic research segment dominated the industry in 2023 due to numerous academic institutes providing bioinformatics courses

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Product
    • 1.1.3. Application
    • 1.1.4. Workflow
    • 1.1.5. End-use
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights

Chapter 3. Japan Next Generation Sequencing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Exponentially decreasing costs for genetic sequencing
      • 3.2.1.2. Development of companion diagnostics and personalized medicine
      • 3.2.1.3. Rise in competition among prominent market entities
      • 3.2.1.4. Rising clinical opportunity for NGS technology
      • 3.2.1.5. Technological advancements in cloud computing and data integration
      • 3.2.1.6. Growing healthcare expenditure supporting development of effective diagnostic & therapeutic procedures for cancer.
      • 3.2.1.7. Increasing prevalence of cancer
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of computational efficiency for data management
      • 3.2.2.2. Non-value-based NGS reimbursement policy and regulation status
      • 3.2.2.3. Challenges associated with NGS implementation.
  • 3.3. Japan Next Generation Sequencing Market Analysis Tools
    • 3.3.1. SWOT analysis; by factor (political & legal, economic, and technological)
    • 3.3.2. Porter's Five Forces Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Japan Next Generation Sequencing Market: Technology Business Analysis

  • 4.1. Next Generation Sequencing Market: Technology Movement Analysis
  • 4.2. Targeted Sequencing & Resequencing
    • 4.2.1. Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.1.1. DNA-based targeted sequencing & resequencing
      • 4.2.1.1.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.2.1.2. RNA-based targeted sequencing & resequencing
      • 4.2.1.2.1. RNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3. Whole Genome Sequencing
    • 4.3.1. Whole Genome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4. Whole Exome Sequencing
    • 4.4.1. Whole Exome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5. Japan Next Generation Sequencing Market: Product Business Analysis

  • 5.1. Next Generation Sequencing Market: Product Movement Analysis
  • 5.2. Platforms
    • 5.2.1. Platforms Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.1. Sequencing
      • 5.2.1.1.1. Sequencing platforms market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2. Data Analysis
      • 5.2.1.2.1. Data analysis platforms market estimates and forecast, 2018 - 2030 (USD Million
  • 5.3. Consumables
    • 5.3.1. Consumables market estimates and forecast, 2018 - 2030 (USD million)
    • 5.3.2. Sample Preparation
      • 5.3.2.1. Sample preparation market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3. Target Enrichment
      • 5.3.3.1. Target enrichment market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Japan Next Generation Sequencing Market: Application Business Analysis

  • 6.1. Next Generation Sequencing Market: Application Movement Analysis
  • 6.2. Oncology
    • 6.2.1. Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2. Diagnostics & Screening
      • 6.2.2.1. Diagnostics & screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2. Oncology screening
      • 6.2.2.2.1. Oncology screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.2. Sporadic cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.3. Inherited cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.3. Companion diagnostics
      • 6.2.2.3.1. Companion diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4. Other diagnostics
      • 6.2.2.4.1. Other diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.2.3. Research Studies
      • 6.2.3.1. Research studies market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3. Clinical investigation
    • 6.3.1. Clinical investigation market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.2. Infectious Diseases
      • 6.3.2.1. Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Idiopathic Diseases
      • 6.3.3.1. Idiopathic diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Inherited Diseases
      • 6.3.4.1. Inherited diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.5. Non-Communicable/Other Diseases
      • 6.3.5.1. Non-communicable/other diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Reproductive Health
    • 6.4.1. Reproductive Health Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2. NIPT
      • 6.4.2.1. NIPT market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2. Aneuploidy
      • 6.4.2.2.1. Aneuploidy market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.2.3. Microdeletions
      • 6.4.2.3.1. Microdeletions market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. PGT
      • 6.4.3.1. PGT market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. Newborn Genetic Screening
      • 6.4.4.1. Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Single Gene Analysis
      • 6.4.5.1. Single gene analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. HLA Typing/Immune System Monitoring
    • 6.5.1. HLA Typing/Immune System Monitoring Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6. Metagenomics, Epidemiology & Drug Development
    • 6.6.1. Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.7. Agrigenomics & Forensics
    • 6.7.1. Agrigenomics & Forensics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.8. Consumer Genomics
    • 6.8.1. Consumer Genomics Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7. Japan Next Generation Sequencing Market: Workflow Business Analysis

  • 7.1. Next Generation Sequencing Market: Workflow Movement Analysis
  • 7.2. Presequencing
    • 7.2.1. Pre-Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.1. NGS library preparation kits
      • 7.2.1.1.1. NGS library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.2.1.2. Semiautomated library preparation
      • 7.2.1.2.1. Semiautomated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.2.1.3. Automated library preparation
      • 7.2.1.3.1. Automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3. Sequencing
    • 7.3.1. Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4. Data Analysis
    • 7.4.1. Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.2. Primary Data Ngs Analysis
      • 7.4.2.1. Primary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Secondary Data Analysis
      • 7.4.3.1. Secondary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. Tertiary Data Analysis
      • 7.4.4.1. Tertiary data analysis market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Japan Next Generation Sequencing Market: End-use Business Analysis

  • 8.1. Next Generation Sequencing Market: End-use Movement Analysis
  • 8.2. Academic Research
    • 8.2.1. Academic Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3. Clinical Research
    • 8.3.1. Clinical Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5. Pharmaceutical & Biotech Entities
    • 8.5.1. Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6. Other Users
    • 8.6.1. Other Users Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Key company market share analysis, 2023
  • 9.4. Participants Overview
    • 9.4.1. Illumina, Inc
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. QIAGEN
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Thermo Fisher Scientific, Inc
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. BGI
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Pacific Biosciences
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Bio Rad Laboratories
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Oxford Nanopore Technologies, Inc
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Myriad Genetics. Inc.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Agilent Technologies, Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Eurofins Scientific
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Japan next generation sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 3 Japan next generation sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Japan next generation sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 5 Japan next generation sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Japan next generation sequencing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Japan next generation sequencing market: market outlook
  • Fig. 7 Japan next generation sequencing competitive insights.
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook.
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 Industry value chain analysis
  • Fig. 12 Japan next generation sequencing market driver impact
  • Fig. 13 Japan next generation sequencing market restraint impact
  • Fig. 14 Japan next generation sequencing market strategic initiatives analysis
  • Fig. 15 Japan next generation sequencing market: Technology movement analysis
  • Fig. 16 Japan next generation sequencing market: Technology outlook and key takeaways
  • Fig. 17 Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 RNA -based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Whole genome sequencing market estimates and forecast, 2018-2030 (USD Million)
  • Fig. 21 Whole exome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Japan Next-generation sequencing market: Product outlook key takeaways
  • Fig. 23 Japan Next-generation sequencing market: Product movement analysis
  • Fig. 24 Platforms market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sequencing platforms market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Data analysis platforms market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Sample preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Target enrichment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Japan next generation sequencing Market: Application Movement Analysis
  • Fig. 32 Japan next generation sequencing market: Application outlook and key takeaways
  • Fig. 33 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Diagnostics & screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Oncology screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Sporadic cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Inherited cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Companion diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Other diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Research studies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Clinical investigation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Idiopathic diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Inherited diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Non-communicable/other diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 NIPT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Aneuploidy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Microdeletions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 PGT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Single gene analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 HLA typing/immune system monitoring market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Metagenomics, epidemiology & drug development market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Agrigenomics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Consumer genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Japan next generation sequencing market: workflow movement analysis
  • Fig. 58 Japan next generation sequencing market: workflow outlook and key takeaways
  • Fig. 59 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 NGS library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Semiautomated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Primary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Secondary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Tertiary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Japan Next generation sequencing market End-use outlook key takeaways
  • Fig. 69 Japan Next-generation sequencing market: End-use movement analysis
  • Fig. 70 Academic research market estimates and forecast, 2018 - 2030 (USD Million))
  • Fig. 71 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Pharmaceutical & biotech entities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Other users market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Market share of key market players- Japan next generation sequencing market